DIANA KIM: Open Payments
NPI 1427513035 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$470 in 15 payments from 8 companies in 2025. Trend: 2023 $1,549 · 2024 $329 · 2025 $470
Food & beverage: $470
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $218 |
| Intra-Sana Laboratories | 3 | $95 |
| PFIZER INC. | 2 | $42 |
| Lundbeck LLC | 1 | $31 |
| Daiichi Sankyo Inc. | 1 | $25 |
| ABBVIE INC. | 1 | $21 |
| Astellas Pharma US Inc | 1 | $21 |
| Exact Sciences Corporation | 1 | $16 |
Products named: Ozempic, RELTONE 200 MG, Wegovy, NURTEC ODT, VYEPTI, INJECTAFER, GLYCATE, VRAYLAR.
Industry payments across NV — which companies pay providers there.
